Dynavax Technologies Corporation
Market Cap
$1.82B
P/E Ratio
-41.89
EPS
$-0.37
Dividend Yield
0.00%
52-Week Range
$9.20 — $15.73
Volume
5.66M
Avg Volume
3.16M
Beta
0.93
Get alerted when DVAX hits your target price.
Free — enter your email to get started
P/E (TTM)
-41.89
Forward P/E
31.59
PEG Ratio
0.08
P/S (TTM)
5.51
P/B (TTM)
3.40
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.08%
ROA (TTM)
-0.05%
ROIC
—
Gross Margin
0.83%
Operating Margin
0.03%
Net Margin
—
Debt/Equity
0.53
Current Ratio
7.62
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+2.32%
EPS Growth (5Y)
+1.88%
Sales Growth (3Y)
+0.05%
Sales Growth (5Y)
+1.78%
EPS Est (This Year)
$0.49
EPS Est (Next Year)
$0.67
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$5.52
Price Target Range
Consensus Target: $27.00(74.2% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
117.42M
Float
100.34M
Free Float %
85.45%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US
Exchange
NASDAQ
IPO Date
2004-02-19
Employees
405
CEO
Ryan Spencer
Index Membership
—
Website
https://www.dynavax.com
Dynavax Technologies Corporation (DVAX) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $1.82B, a P/E ratio of -41.89, DVAX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare DVAX against other stocks using dozens of fundamental and technical filters.
Dynavax Technologies Corporation (DVAX) has a trailing twelve-month (TTM) P/E ratio of -41.89. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Dynavax Technologies Corporation (DVAX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Dynavax Technologies Corporation (DVAX) has a market capitalization of $1.82 billion, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.